相似文献
1
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.甲基强的松龙治疗多发性硬化症：不良反应概述
J Neurol Neurosurg Psychiatry. 1988 Feb;51(2):285-7. doi: 10.1136/jnnp.51.2.285.
2
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
Lancet. 1997 Jun 7;349(9066):1696-7. doi: 10.1016/S0140-6736(05)62664-5.
3
[Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].[对《多发性硬化治疗共识小组对多发性硬化的免疫调节阶段性治疗》一文的评论]
Nervenarzt. 2002 Dec;73(12):1207; author reply 1207.
4
Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.甲基泼尼松龙治疗多发性硬化症：等效高剂量口服与静脉治疗的比较
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1219-20. doi: 10.1136/jnnp.56.11.1219.
5
[Steroid therapy for multiple sclerosis].[用于多发性硬化症的类固醇疗法]
Nihon Rinsho. 2003 Aug;61(8):1361-6.
6
7
Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.静脉注射大剂量甲泼尼龙治疗多发性硬化症患者所致各种心律失常和传导障碍的发生率。
J Neurol Sci. 2011 Oct 15;309(1-2):75-8. doi: 10.1016/j.jns.2011.07.018. Epub 2011 Aug 9.
8
9
Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.口服与静脉注射甲泼尼龙治疗多发性硬化复发：随机对照试验的荟萃分析。
PLoS One. 2017 Nov 27;12(11):e0188644. doi: 10.1371/journal.pone.0188644. eCollection 2017.
10
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.口服与静脉注射大剂量甲泼尼龙治疗多发性硬化症复发的比较（COPOUSEP）：一项随机、对照、双盲、非劣效性试验。
Lancet. 2015 Sep 5;386(9997):974-81. doi: 10.1016/S0140-6736(15)61137-0. Epub 2015 Jun 28.
引用本文的文献
1
Improving Glucocorticoid Sensitivity of Brain-Homing CD4 T Helper Cells by Steroid Hormone Crosstalk.通过甾体激素串扰改善归巢大脑的 CD4 辅助性 T 细胞的糖皮质激素敏感性。
Front Immunol. 2022 May 26;13:893702. doi: 10.3389/fimmu.2022.893702. eCollection 2022.
2
Use of Intravenous Pulse Steroids to Treat Allergic Bronchopulmonary Aspergillosis in a Non-Compliant Asthmatic Adolescent.在一名不依从治疗的哮喘青少年中使用静脉脉冲类固醇治疗变应性支气管肺曲霉病
Children (Basel). 2022 Feb 14;9(2):252. doi: 10.3390/children9020252.
3
A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.关于用于重症新型冠状病毒肺炎以预防细胞因子风暴的全身性皮质类固醇激素的作用及副作用的综述
EXCLI J. 2021 Feb 15;20:339-365. doi: 10.17179/excli2020-3196. eCollection 2021.
4
How to run a multiple sclerosis relapse clinic.如何运营一家多发性硬化症复发诊所。
Pract Neurol. 2016 Feb;16(1):62-9. doi: 10.1136/practneurol-2015-001214. Epub 2015 Nov 11.
5
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.一名接受脉冲剂量类固醇治疗多发性硬化症的女性出现急性症状性窦性心动过缓：病例报告
J Med Case Rep. 2015 Sep 24;9:216. doi: 10.1186/s13256-015-0701-x.
6
VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.新型抗炎药VBP15可有效减轻小鼠实验性自身免疫性脑脊髓炎的严重程度。
Cell Mol Neurobiol. 2015 Apr;35(3):377-387. doi: 10.1007/s10571-014-0133-y. Epub 2014 Nov 13.
7
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.临床孤立综合征及多发性硬化诊断标准的最新进展。
Neurohospitalist. 2013 Apr;3(2):65-80. doi: 10.1177/1941874412457183.
8
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.多发性硬化症、复发和促肾上腺皮质激素的作用机制。
Front Neurol. 2013 Mar 8;4:21. doi: 10.3389/fneur.2013.00021. eCollection 2013.
9
Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.多发性硬化症患者胃酸生成的药物抑制的潜在免疫学后果。
BMC Med. 2012 Jun 7;10:57. doi: 10.1186/1741-7015-10-57.
10
Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.地拉罗司能调节来自对照和复发缓解型多发性硬化症患者外周血 T 细胞的体外反应。
Int Immunopharmacol. 2011 Nov;11(11):1796-801. doi: 10.1016/j.intimp.2011.07.007. Epub 2011 Jul 30.
本文引用的文献
1
Epilepsy and disseminated sclerosis.癫痫与播散性硬化症。
Q J Med. 1962 Apr;31:141-55.
2
The electroencephalogram of multiple sclerosis; a preliminary report.多发性硬化症的脑电图；初步报告。
Dis Nerv Syst. 1959 Jan;20(1):41-4.
3
Fatal arrhythmia after pulse methylprednisolone therapy.脉冲式甲泼尼龙治疗后出现致命性心律失常。
Ann Intern Med. 1981 Dec;95(6):781-2. doi: 10.7326/0003-4819-95-6-781_3.
4
Methylprednisolone therapy in multiple sclerosis.甲基强的松龙治疗多发性硬化症。
J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):941-2. doi: 10.1136/jnnp.45.10.941.
5
Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone.静脉注射甲基强的松龙治疗多发性硬化急性加重期
J Neurol Neurosurg Psychiatry. 1982 Feb;45(2):179-80. doi: 10.1136/jnnp.45.2.179-a.
6
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.大剂量静脉注射类固醇疗法在急性脱髓鞘疾病和横贯性脊髓炎中的潜在有益作用。
Neurology. 1980 Jul;30(7 Pt 2):33-6. doi: 10.1212/wnl.30.7_part_2.33.
7
Cyclosporin A, methylprednisolone, and convulsions.环孢素A、甲基强的松龙与惊厥
Lancet. 1982 Oct 9;2(8302):829-30. doi: 10.1016/s0140-6736(82)92727-1.
8
A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease.
Lancet. 1982 Jul 31;2(8292):237-40. doi: 10.1016/s0140-6736(82)90323-3.
9
Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy.静脉注射甲泼尼龙琥珀酸钠：与免疫抑制治疗相关的不良反应报告。
Transplant Proc. 1973 Jun;5(2):1145-6.
10
The effect of massive pulse steroid therapy on the water content of the rat brain.
Transplantation. 1972 Sep;14(3):403-5.
Zotero 插件